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Background: Enterocin A is a classic IIa bacteriocin isolated firstly from Enterococcus faecium CTC492 with selective
antimicrobial activity against Listeria strains. However, the application of enterocin A as an anti-Listeria agent has
been limited due to its very low native yield. The present work describes high production of enterocin A through
codon optimization strategy and its character study.
Results: The gene sequence of enterocin A was optimized based on preferential codon usage in Pichia pastoris to
increase its expression efficiency. The highest anti-Listeria activity reached 51,200 AU/ml from 180 mg/l of total
protein after 24 h of induction in a 5-L fermenter. Recombinant enterocin A (rEntA), purified by gel filtration
chromatography, showed very strong activity against Listeria ivanovii ATCC 19119 with a low MIC of 20 ng/ml. In
addition, the rEntA killed over 99% of tested L. ivanovii ATCC19119 within 4 h when exposed to 4 × MIC (80 ng/ml).
Moreover, it showed high stability under a wide pH range (2–10) and maintained full activity after 1 h of treatment
at 80°C within a pH range of 2–8. Its antimicrobial activity was enhanced at 25 and 50 mM NaCl, while 100–400 mM
NaCl had little effect on the bactericidal ability of rEntA.
Conclusion: The EntA was successfully expressed in P. pastoris, and this feasible system could pave the pre-industrial
technological path of rEntA as a competent candidate as an anti-Listeria agent. Furthermore, it showed high stability
under wide ranges of conditions, which could be potential as the new candidate of anti-Listeria agent.
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Bacteriocins are antimicrobial peptides synthesized in
the ribosome and secreted into medium to establish a
competitive advantage in their environment by eliminat-
ing competitors to gain resources [1]. Bacteriocins are
generally classified in terms of size, structure, and modi-
fications. Class I bacteriocins are lantibiotics. Class II
bacteriocins consist of small peptides that do not con-
tain modified residues. Class III bacteriocins usually are
large and heat-labile proteins [2]. The well-known bac-
teriocin is nisin, a class I bacteriocin, which is widely
used in commerce [3]. Recently, many reports clearly* Correspondence: hjz@fjnu.edu.cn; 2681298635@qq.com
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unless otherwise stated.indicate that bacteriocins of class IIa have greater poten-
tial as antimicrobial agents [4] with a narrower inhibi-
tory spectrum to Listeria strains than nisin [5]. Listeria,
the most common pathogen in food, can lead the host
to suffer from serious diseases such as enteritis, sepsis,
meningitis and abortion [6]. The mortality rate caused
by listeriosis is between 15 and 30% [7,8]. Additionally,
some strains of L. monocytogenes easily acquire resistance
to many antibiotics [9]. To control food contamination
and listeriosis effectively, more or better anti-listerial drugs
are needed.
Enterocin A (EntA), with many antimicrobial merits, is
a class IIa bacteriocin that was first isolated from Entero-
coccus faecium CTC492 in the mid-1990s. Its mature
form is composed of 47 amino acids with two disulfide
bridges [10]. It shows high activity, particularly against
Listeria species at nanomolar concentrations [11]. The
native EntA has proven to effectively inhibit L. monocy-
togenes in fermented foods [12,13]. However, the lowThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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not meet the requirements of the industrial scale and
have limited its application to study stages thus far.
Therefore, various heterologous expressions were
attempted in lactic acid bacteria, Escherichia. coli (E.coli)
and yeast [12,14-16], but their actual production levels
were not desirable and left room for improvement.
Pichia pastoris is considered to be a promising system
because the target protein can be directly secreted into
culture medium. It was reported that the production and
bactericidal titer of enterocin P expressed by P. pastoris
X-33 was 3.7- and 16-fold higher (28.2 μg/ml and 1,024
BU/ml), respectively, than that from the native
E. faecium P13 [17]; in fact, even though the level of
45.1 μg/ml of recombinant enterocin A expressed by
P. pastoris [18] was still too low for its industrial produc-
tion and end application, it demonstrates the potential to
increase its productivity to be as high as possible and to
further easily characterize its purification and properties.
However, there are only few studies at the modification
of bacteriocin genes, such as gene synthesis or codon
optimization, which is considered as a promising tech-
nique for increasing protein expression level [19]; thus,Figure 1 Construction of the expression plasmid pPICZαA-EntA. A, Th
sequence. The upper line indicates the wild-type EntA gene sequence. The
codons are underlined with boldface type. The lower line represents the am
asterisk. B, Map of the recombinant plasmid pPICZαA-EntA. C, Electrophore
Lane 1, DNA marker; lane 2, pPICZαA-EntA digested by XhoI and XbaI.further work with this system is necessary to achieve an
increased protein expression level of target gene.
Due to the high anti-Lister activity of EntA and its low
yield either in native strain and recombinant expression
system, the EntA gene was optimized by the preferential
codon usage of P. pastoris and was expressed into
medium as recombinant EntA (rEntA). The purification
of rEntA from ferment supernatant was tried by four
methods including gel filtration chromatography, then
the antimicrobial activity, proteolytic sensibility and sta-
bilities of heat, pH and salt of purified rEntA were
examined.
Results
Construction and transformation of the expression vector
Compared to naturally occurring EntA, the base codons
coding for 37 residues (78.72%) in total 47 amino acids
were optimized by the preferential codon usage of P.
pastoris (Figure 1A). The GC content of the full target
sequence increased from 41.13% to 41.9%. The gene se-
quence of the optimized EntA was synthesized and
inserted into pPICZαA between XhoI and XbaI sites
(Figure 1B, C). The expression vector pPICZαA-EntAe nucleotide sequence of EntA and its corresponding amino acid
middle line is the codon-optimized EntA gene sequence. Optimized
ino acid sequence of EntA. The termination codon is marked by an
tic analysis of the recombinant vector containing the EntA gene.
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Resulting transformants were confirmed by PCR and
DNA sequencing. Correct plasmid and control vector
pPICZαA were linearized by PmeI and transferred into
competent P. pastoris X-33 cells by electroporation.
Positive transformations were screened and confirmed
by colony PCR.
Expression of rEntA in shake flasks and at the fermenter
level
The heterologous expression of rEntA in P. pastoris X-
33 was induced by methanol at the concentration of
0.5% and analyzed by agar diffusion and Tricine-SDS-
PAGE. P. pastoris X-33 containing the empty pPICZαA
vector was used as a negative control. As shown in
Figure 2A, after 12 h of methanol induction, the antibac-
terial activity of the supernatants of P. pastoris X-33
(pPICZαA-EntA) was observed. Its antibacterial activity
reached maximum with 6,400 AU/ml after 24 h of
methanol induction. However, the antimicrobial activity
decreased from 48 to 72 h. No antibacterial activity was
detected in the supernatants of P. pastoris X-33 (pPIC-
ZαA). The results of the MALDI-TOF MS for fermenta-
tion supernatants indicated that the molecular weight of
rEntA was 4,830.1 Da, which was consistent with its the-
oretical value of 4,829 Da (Figure 2E).
To increase the production of rEntA, high-density fer-
mentation of the recombinant yeast was performed
using a 5-L fermenter. Although the total supernatant
protein and biomass reached 365 mg/l and 343 g/l after
induction for 90 h, the maximal antimicrobial activity
was 51200 AU/ml (180 mg/l) after induction for 24 h
(Figure 2C), which was 8-fold higher than that found at
the shake-flask level. Figures 2B and D clearly showed
that rEntA was rapidly degraded after 72 h of induction.
Moreover, the expression of rEntA in the fermenter
could be detected directly by Coomassie blue staining
(Figure 2D), while its expression in the shake-flask could
only be detected by silver staining (data not shown).
Purification of rEntA
The rEntA was purified from the ferment supernatant
after a 24-h induction in a 5-L fermenter. The bacteri-
ocin activity of 6.40 × 105 AU/mg with a 2.25-fold in-
crease was obtained after gel filtration. The purified
rEntA was analyzed by Tricine-SDS–PAGE and showed
a band at 4.8 kDa representing the target protein band
(Figure 2F), corresponding with its theoretical molecular
weight.
Antimicrobial spectrum of rEntA
Only L. ivanovii ATCC19119, E. faecalis CGMCC1.130
and E. faecalis CGMCC1.2024 were sensitive to rEntA
in the 16 tested strains. Other Gram-positive bacteria,such as E. faecium CGMCC1.2136, S. aureus ATC-
C25923, S. epidermidis ATCC26069, B. licheniformis
CGMCC1.265, and B. coagulans CGMCC1.2407, were
found to be resistant to rEntA. All of the Gram-negative
bacteria strains were resistant to rEntA in this assay
(Table 1). The MIC and MBC of rEntA against L. ivano-
vii ATCC19119 were 20 ng/ml and 80 ng/ml, res-
pectively, and were lower than those of ampicillin
(390 ng/ml and 1560 ng/ml, respectively).
In-vitro killing curve assay
The time-killing kinetics curve showed that the amount
of L. ivanovii ATCC19119 increased from 6.63
log10CFU/ml to 9.48 log10CFU/ml within 10 h in the ab-
sence of rEntA. The decrease in the counts of L. ivanovii
ATCC19119 varied considerably depending on the con-
centration of rEntA. For example, the maximum viability
loss (MVL), which was approximately 0.44 log10 CFU/ml
(~60% reduction in CFU), was reached within 2 h in 1 ×
MIC of rEntA. The 2 ×MIC of rEntA could cause ap-
proximately 1.42 log10 CFU/ml viability loss (96% reduc-
tion) within 6 h. Moreover, the MVL of L. ivanovii
treated by rEntA at 4 ×MIC was approximately 2.03
log10 CFU/ml (>99% reduction in CFU) within 4 h. Al-
though rEntA could inhibit the growth of L. ivanovii
ATCC19119, the survivors resumed growth at 1× and
2 ×MIC of rEntA and 2 ×MIC ampicillin for L. ivanovii
ATCC19119 after MVL was achieved (Figure 3). How-
ever, L. ivanovii ATCC19119 treated by 4 ×MIC of
rEntA did not show re-growth within 10 h, revealing
that 80 ng/ml rEntA could effectively inhibit the growth
of pathogenic bacteria for an extended time.
Effects of pH, temperature, proteolytic enzymes and NaCl
on the activity of rEntA
As shown in Figure 4A, rEntA was highly stable at a
wide range of pH values. The activity of rEntA was
maintained completely within a pH range of 2–8 at 37°C
for 12 h and was 75% retained even after incubation at a
pH of 10 for 12 h. Furthermore, the antimicrobial activ-
ity of rEntA was not affected by heat treatment at 37,
60, 80 and 100°C for 1 h under acid conditions (pH 2
and 4) (Figure 4B). The residual activity decreased to 20%
at a pH of 10 at 80°C, to 50% at a pH of 6, 8 at 100°C, and
to 10% at a pH of 10 at 100°C. In addition, the antimicro-
bial activity of rEntA was completely abolished by pepsin
and trypsin treatment, but it retained 16.7% of initial anti-
microbial activity after papain treatment at 37°C for 1 h
(Figure 4C).
The antimicrobial activity of rEntA against L. ivanovii
ATCC19119 was slightly enhanced by the addition of 25
and 50 mM NaCl (Figure 5). The lowest amount of 2.43
log10 CFU/ml was observed with a treatment of rEntA
(12,800 AU/ml) in 25 mM NaCl (44.52% of that at
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Figure 2 Expression and purification of rEntA. A, Total secreted protein level and antimicrobial titer of the fermentation supernatants of recombinant
P. pastoris at the shake-flask level (bars represent the standard error of the mean). B, Antimicrobial activity of the fermentation supernatants of
recombinant P. pastoris at the fermenter level. 1–9, 50 μl supernatant taken at 0, 12, 24, 36, 48, 60, 72, 84, and 90 h of induction, respectively; 10, 1 μg
ampicillin. C, The total secreted protein level and antimicrobial titer in the fermenter level (bars represent the standard error of the mean). D, Tricine-
SDS-PAGE analysis of rEntA secreted in the fermentation supernatant of P. pastoris cultures at the fermenter level. Lane M, 5 μl molecular mass standards
(from top to bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa); Lanes 1–9, 20 μl supernatant taken at 0, 12, 24, 36, 48, 60, 72, 84 and 90 h of induction, respectively.
E, MALDI-TOF map of rEntA. F, Purification and identification of rEntA. Lane 1, purified rEntA (0.1 μg); Lane M, 5 μl molecular mass standards (from top to
bottom: 40, 25, 15, 10, 4.6 and 1.7 kDa). Lane 2, 10 μl of rEntA supernatant taken at 24 h of induction.
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Table 1 Antimicrobial spectrum of rEntA
Strains Antimicrobial activity
Gram-positive
Listeria ivanovii ATCC19119 +
Enterococcus faecium CGMCC1.2136 -
Enterococcus faecalis CGMCC1.130 +
Enterococcus faecalis CGMCC1.2024 +
Staphylococcus aureus ATCC 25923 -
Staphylococcus epidermidis ATCC26069 -
Bacillus licheniformis CGMCC1.265 -
Bacillus coagulans CGMCC1.2407 -
Bacillus subtilis ATCC6633 -
Lactococcus lactis (Stored in our lab) -
Bifidobacterium bifidum CGMCC1.2212 -
Gram-negative -
E. coli ER2566 -
E. coli CVCC 195 -
E. coli CMCC 44102 -
Pseudomonas aeruginosa CVCC 2087 -
Salmonella enteritidis CVCC3377 -
Note: “+” refers to positive antimicrobial activity (inhibition zone > 6 mm);
“-” refers to negative antimicrobial activity (inhibition zone ≤ 6 mm).
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400 mM NaCl, had no significant effect on the bacteri-
cidal ability of rEntA (Figure 5). In the controls without
rEntA, growth was not influenced by NaCl (0 –












Figure 3 Time-kill curves of rEntA. L. ivanovii ATCC19119 was incubated
MIC of rEntA. Ampicillin of 2 × MIC was used as a positive control. Three du
the mean.Discussion
Bacteriocin has attracted attention in recent years for its
potential application as a food preservative and thera-
peutic antimicrobial agent [20]. However, low produc-
tion of these bacteriocins by native strains cannot meet
the requirements of commercial applications. Moreover,
some Enterococci strains were recognized as opportunis-
tic pathogens associated with lots of infections [21]. At-
tempts to produce bacteriocins by using safe heterologous
hosts have been undertaken in recent years [17,22,23], in-
cluding some typical expression systems such as E. coli, L.
lactis, and P. pastoris. Although E. coli and L. lactis are
widely used in heterologous protein expression because of
their easy operation and safety [14,24], they are not suit-
able for bacteriocins due to toxicity to the host [25] and
low recovery percentages from the fusion protein [26].
Many bacteriocins, such as enterocin P [17], hiracin JM79
[27], enterocin L50 [28], pediocin PA-1 [29] and EntA
[18], have been expressed as active forms in P. pastoris,
but their expression levels remained low (below 280 mg/l).
It is known that codon optimization is a useful strategy to
increase the yield of target protein during heterogeneous
expression. Many antimicrobial peptides, such as plectasin
[30], NZ2114 [31] and AgPlectasin [32], were expressed
with high production through codon-usage optimization
in our laboratory. In addition, Divercin V41, a class IIa
bacteriocins was also expressed through this system [33].
These cases encouraged us to use codon optimization to
break through the bottleneck of low yield in heterologous
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Figure 4 Effects of pH, temperature and proteolytic enzymes on the rEntA activity. A, pH stability of rEntA. Purified rEntA was incubated in
buffers with a pH range from 2 to 10 at 37°C for 12 h. The initial activity of the sample in a buffer with a pH of 6 was described as 100% activity.
B, Thermal stability of EntA. Purified rEntA was incubated in buffers with a pH range from 2 to 10 at temperatures of 37, 60, 80, and 100°C for 1 h.
The initial activity of the sample in a buffer with a pH of 6 was described as 100% activity. C, Proteolysis resistance of rEntA. Purified rEntA was
incubated with pepsin, papain and trypsin at 37°C for 4 h. The residual antimicrobial activity of samples was tested after the pH was readjusted to
pH 6.0 with sodium phosphate buffer.
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51,200 AU/ml at 24 h of induction in 5-L fermenter level
(Figure 2C) after the gene was optimized. Although the
yield of target peptide was still low, and even lower than
280 mg/l as the highest result of expression in case ofenterocin L50 in P. pastoris [28], it was much higher than
that of Pediocin PA-1 (0.4 mg/l), Enterocin P (0.006 mg/l),
Divercin V41 (23 mg/l) and EntA (0.027 mg/l) expressed
in E. coli and L. lactis [14,22,33]. Furthermore, the produc-
tion of rEntA increased 2.99-times compared with its
Figure 5 Effect of NaCl concentration on the activity of rEntA. Control: L. ivanovii ATCC19119 was incubated in the absence of rEntA. 4 × MIC:
L. ivanovii ATCC19119 was incubated in the presence of rEntA at 4 × MIC.
Hu et al. BMC Microbiology 2014, 14:220 Page 7 of 11
http://www.biomedcentral.com/1471-2180/14/220native sequence expressed in P. pastoris (45.1 mg/l), which
indicated codon optimization is a good tool to enhance
expression efficiency and level in P. pastoris, and at the
same time, it also left a large room to improve in future
work at the similar aim and technical scheme.
However, the maximal activity of rEntA in the super-
natant was reached at an early stage (24 h) of induction
(Figure 2C). This is similar to previous results in which
the highest level of rEntA was reached at 36 h. An even
earlier peak of rEntA at 6 h was observed in other yeasts
such as Kluyveromyces lactis and Hansenula polymorpha
[18]. Obviously, its final successful application suffered
from this strong decomposition in the supernatant at an
earlier period of expression related to the possible dis-
ruption of rEntA to host cells and the proteolysis of the
target protein. The latter situation was reported in “col-
lagen-like” bacteriocin with a high cleavage by collage-
nase [29]. However, the exact mechanism of the above
described early degradation and its solution should be
further studied.
A series of methods, such as ion exchange chromatog-
raphy (SP and CM FF), hydrophobic exchange chroma-
tography (Phenyl HP), and gel filtration (Superose 12),
were attempted to purify rEntA in this study. Only gel
filtration could purify rEntA with a yield of 3.02 mg/l
(Figure 2F) after attempts with SP FF, CM FF, and
phenyl HP in which almost all rEntA was lost in the
penetration peak (data not shown) due to unknown
reasons.
Although there are different antibacterial spectrums
between class IIa bacteriocins, they consistently have
particularly high antibacterial activity against Listeria —the most common pathogen in food — at nanomolar
concentrations [1]. The MICs of purified native EntA
from E. faecium T136 against Listerias ranged from 40
to 120 ng/ml [34]. Similarly, rEntA also showed a nar-
row antibacterial spectrum (Table 1) including L. ivano-
vii ATCC19119, and with a low MIC value of 20 ng/ml,
it is approximately 20-fold lower than that of ampicillin
(390 ng/ml). The re-growth after MVL achievement
was a common phenomenon when the Listeria was
treated with bacteriocins such as EntA, pediocin, sakacin
A and enterococcin EFS2 in relatively low concentra-
tions (1× or 2 ×MIC) [3], but we found no re-growth
after MVL within 10 h when 4 ×MIC rEnA was used
with the Listeria (Figure 3), indicating that higher con-
centrations of rEnA are essential to inhibit the multipli-
cation of Listeria.
The bactericidal activity and overall structure of Pedio-
cin PA-1 and piscicolin 126 were well maintained at
higher temperatures [35,36]. The native EntA was stable
at 100°C and acidic pH conditions [37]. We found that
rEntA also exhibited high stability under a wide range of
temperatures (37–80°C) and pH levels (2–8) (Figure 4).
These properties were potentially due to the higher cyst-
eine content of the antimicrobial peptides [38], similar
to the EntA containing four cysteine residues. In
addition, the antimicrobial activity of some bacteriocins
(nisin, sakacin P and curvacin A) was significantly en-
hanced with the addition of NaCl from 0 to 1.17 M [39].
However, the activity of rEntA against Listeria was en-
hanced only at low NaCl concentrations (25 and
50 mM). Despite the unknown mechanisms of the above
differential effects, the high stability of rEntA over wide
Table 2 Strains used in the antimicrobial activity assays
Strains Source
Gram-positive
Listeria ivanovii ATCC19119 CICCa
Enterococcus faecium CGMCC1.2136 CGMCCb
Enterococcus faecalis CGMCC1.130 CGMCC
Enterococcus faecalis CGMCC1.2024 CGMCC
Staphylococcus aureus ATCC 25923 CVCCc
Staphylococcus epidermidis ATCC26069 CVCC
Bacillus licheniformis CGMCC1.265 CGMCC
Bacillus coagulans CGMCC1.2407 CGMCC
Bacillus subtilis ATCC6633 CVCC
Lactococcus lactis Stored in our lab
Bifidobacterium bifidum CGMCC1.2212 CGMCC
Gram-negative
Escherichia. coli ER2566 CGMCC
Escherichia. coli CVCC 195 CVCC
Escherichia. coli CMCC 44102 CMCCd
Pseudomonas aeruginosa CVCC 2087 CVCC
Salmonella enteritidis CVCC3377 CVCC
Note: aChina Center of Industrial Culture Collection, bChina General
Microbiological Culture Collection, cChina Veterinary Culture Collection, dChina
Center for Medical Culture Collection.
Hu et al. BMC Microbiology 2014, 14:220 Page 8 of 11
http://www.biomedcentral.com/1471-2180/14/220ranges of temperature, pH, and NaCl concentration sup-
ports its use as a food preservative and drug candidate.
Due to the high content of basic and aromatic amino
acids in class IIa bacteriocins, pediocin PA-1, enterocin
B, plantaricin 423 and native EntA were very sensitive to
the digestive proteases trypsin and pepsin [11,40,41].
Similarly, the purified rEntA, with 12.76% basic amino
acids and 10.63% aromatic amino acids, was inactivated
with trypsin and pepsin (Figure 4C). This high sensitivity
to digestive proteases of rEntA contributes to its safety
in foods and drugs, during and after oral administration.
Conclusion
In conclusion, rEntA, as an antimicrobial agent with
merit, could selectively kill important and pathogenic
Listeria and retain bio-activity over a wide range of pH
values, temperature and NaCl concentrations. These ex-
cellent antibacterial properties make it a potential candi-
date as a food preservative and therapeutic antimicrobial
agent. rEntA was successfully expressed in P. pastoris X-
33 at the highest level of 51,200 AU/ml and was purified
through a gel filtration column. This yeast system may
be a feasible technological approach to produce rEntA
as a potent anti-Listeria agent after further optimization.
Methods
Strains and vectors
Escherichia coli DH5α, Pichia pastoris X-33 and pPIC-
ZαA were purchased from Invitrogen (Beijing, China).
Target strains for the antimicrobial activity assays are
listed in Table 2. Restriction enzymes were purchased
from New England Biolabs (NEB, Beijing, China). The
kits for plasmid extraction and DNA purification were
purchased from Tiangen (Beijing, China). Other chem-
ical reagents used in this research were all of analytical
grade.
Construction of the expression vector and transformation
The optimized EntA gene (GenBank accession No.
KJ155693) was generated by the ‘ReverseTranslateTool’
(http://www.bioinformatics.org/sms2/rev_trans.html) ac-
cording to the codon usage of P. pastoris (http://www.
kazusa.or.jp/codon/). To express the target protein with
a native N-terminus, the Kex2 signal cleavage site was
fused to the EntA sequence. The designed sequence was
synthesized by Sangon Biotech (Shanghai, China) and
digested using XhoI and XbaI. Resulting DNA fragments
were ligated into pPICZαA to generate the recombinant
vector pPICZαA-EntA. The latter was transformed into
E. coli DH5α, and positive transformants were confirmed
by DNA sequencing. The recombinant plasmid was line-
arized with PmeI and transformed into P. pastoris X-33
competent cells by electroporation [30]. Positive trans-
formants were screened on YPDS medium containing100 μg/ml of zeocin and further confirmed by colony-
PCR.
Expression of rEntA at the shake-flask level
The positive transformants were grown in BMGY
medium until the cultures reached an OD600 nm of
5.0–6.0 at 30°C. Cells were harvested by centrifugation
at 4000 rpm for 10 min and resuspended in BMMY
medium to an OD600 nm of 1.0. Methanol was added
daily to a final concentration of approximately 0.5%.
Samples were taken at 0, 12, 24, 36, 48, 60 and 72 h for
analysis.
Expression of rEntA at the fermenter level
A single colony of P. pastoris X-33 (pPICZαA-EntA) was
grown in 10 ml of YPD medium at 30°C overnight. The
culture was inoculated into 200 ml fresh YPD medium
and cultivated at 29°C to an OD600 nm of approxi-
mately 6.0. The 200-ml seed culture was transferred into
a 5-L fermenter (Sartorius StedimBiotech) containing
1.8 L of basal salt medium with 45 g/L of NH4H2PO4,
20 g/L K2SO4, 0.4 g/L CaSO4, 15 g/L MgSO4 7H2O, 6
g/L KH2PO4, 1.5 g/L KOH, and 200 ml 45% w/v glucose.
The initial fermentation was a glucose batch phase (ap-
proximately 18 h). After exhaustion of the glucose,
50% w/v glucose was added for 6 h at a feed rate of
36 ml/h. After the glucose was exhausted, methanol was
Hu et al. BMC Microbiology 2014, 14:220 Page 9 of 11
http://www.biomedcentral.com/1471-2180/14/220supplied from 2 to 12 ml/h. The whole fermentation
period was performed at 29°C. During the glucose batch
and glucose-fed phases, the pH was kept at 5.0 and in-
creased to 5.5 at the methanol induction phase [42]. The
protein in the supernatant was determined by the Brad-
ford protein assay (Tiangen, Beijing, China) and Tricine-
SDS–PAGE [43].Purification of rEntA
The supernatant with rEntA from P. pastoris X-33
(pPICZαA-EntA) X-33 was desalted by a gel filtration
column (Sephadex G-25) with a flow rate of 2 ml/min
and then freeze-dried and dissolved in 100 mM of am-
monium acetate buffer. The sample was passed through
a gel filtration column (Superose 12) and eluted with the
same buffer at a flow rate of 0.5 ml/min. Purified rEntA
was further lyophilized to remove ammonium acetate.Antimicrobial activity assay
Tested strains including L. ivanovii, E. faecalis, and E. fae-
cium were grown in Mueller-Hinton (MH) broth contain-
ing 3% fetal bovine serum (FBS). S. epidermidis, B. subtilis,
L. lactis, B. bifidum, B. licheniformis, B. coagulans and S.
aureus were grown in MH broth. P. aeruginosa, E. coli
and S. enteritidis were grown in LB medium. All tested
strains were grown to 0.4 of OD600 nm at 37°C. One hun-
dred microliters of the cell suspension was inoculated into
50 ml of preheated medium containing 1.5% agar. This
was rapidly mixed and poured into a Petri dish. Sterile Ox-
ford cups were put on the surface of the solidified media.
Each cup was filled with 50 μl of samples [30].
Titer assays were used to quantify the antimicrobial
activity of rEntA according to the method of Liu [12].
The titer was expressed as arbitrary units (AU/ml). One
arbitrary unit (AU) was defined as the reciprocal of the
highest dilution showing a clear zone of inhibition to the
indicator strain. When a clear inhibition zone was
followed by a turbid one, the critical dilution was taken
to be the average of the final two dilutions.
Minimal inhibitory concentrations (MICs) and Mini-
mum bactericidal concentrations (MBCs) assays were
determined using the microtiter broth dilution method
[30]. Ampicillin was also tested with the same concen-
tration gradient as a positive control. All tests were per-
formed in triplicate.In-vitro killing curve assay
To evaluate the antibacterial activity of rEntA against L.
ivanovii ATCC19119, a time-kill assay was performed as
described by the methods of Mao [32]. In addition, tubes
with only bacterial inoculum were used as growth con-
trols. All experiments were performed in triplicate.Effects of pH, temperature, proteases and NaCl on the
activity of rEntA
The effects of pH, temperature and proteases on rEntA
activity were determined as described previously [30,44]
with the following modifications: 1) The titer of purified
rEntA used in the test was 12,800 AU/ml; 2) The initial
activity of sample in the buffer with a pH of 6 was taken
as 100% activity for pH and thermal stability assays; and 3)
The residual antimicrobial activity of samples was tested
after the pH was readjusted to 6.0 with sodium phosphate
buffer (pH 6.0) for the proteolytic sensibility assay.
To evaluate the effect of NaCl concentration on the
activity of rEntA, an overnight culture of L. ivanovii
ATCC19119 was diluted to 105–6 CFU/ml in fresh MHB
medium (3% FBS). Ten microliters of purified rEntA and
10 μl of NaCl solution were added to 80 μl of diluted
cell culture. The final rEntA concentration was 4 ×MIC,
and the final NaCl concentrations were 0, 25, 50, 100,
200, and 400 mM. Samples without rEntA were used as
controls. All samples were incubated at 37°C for 10 h.
The CFU of tested strains was determined. All tests were
performed in triplicate.
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